Success Story: Advancing Immune-Based Therapies for Infectious Diseases Leads to NIW Approval for an Immunology Researcher
Client’s Testimonial:
"Many thanks for your help throughout this process, really appreciate it!”
On August 12th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Fellow in the Field of Immunology (Approval Notice).
General Field: Immunology
Position at the Time of Case Filing: Postdoctoral Research Fellow
Country of Origin: Sri Lanka
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: August 12th, 2026
Processing Time: 2 months, 17 days (Premium Processing Upgrade Requested)
Case Summary:
Developing more effective ways to protect vulnerable populations from infectious diseases remains an important public health challenge. This challenge forms the foundation of the client’s work in immunology.
Holding a Ph.D. in immunology, the client specialized in studying immune responses and developing immune-based therapies for infectious diseases. The client was conducting research at a U.S. academic institution and planned to continue investigating how factors such as aging and complex health conditions could affect the body’s ability to respond to infectious diseases. The research combined studies involving human populations, detailed biological analysis, experimental approaches, and computational methods to support the development of more effective preventive and therapeutic strategies.
North America Immigration Law Group (Chen Immigration Law Associates) demonstrated that the client’s proposed endeavor has significance extending beyond any single institution. We connected the research to broader U.S. needs involving infectious disease prevention and treatment, improved outcomes for vulnerable populations, public health preparedness, and continued biomedical innovation. We also highlighted how the client’s work addresses health challenges and research priorities recognized by U.S. government agencies.
The client’s research record provided further evidence of the ability to advance this endeavor. At the time of filing, the client’s scholarly record included:
- 4 peer-reviewed journal articles, including 2 first-authored publications
- 1 first-authored preprint
- 33 citations
The client’s research had also received support from multiple government funding sources, including the National Institute of Allergy and Infectious Diseases, the State of North Carolina Coronavirus Aid, Relief, and Economic Security (CARES) Act, and the National Center for Advancing Translational Sciences.
We also demonstrated how independent researchers had relied on the client’s findings to inform subsequent work involving immune responses, disease prevention, and improved approaches for protecting against infectious diseases. By showing how other researchers incorporated and built upon these findings, we demonstrated that the client’s work had already influenced further research in the field.
By connecting the client’s academic background, scholarly accomplishments, independent research influence, government-supported work, and future plans to broader U.S. public health needs, North America Immigration Law Group (Chen Immigration Law Associates) presented a cohesive case for the client’s continued contributions. The I-140 NIW petition was approved on August 12th, 2026. We congratulate the client on this achievement and wish the client continued success in advancing immune-based therapies and improving protection against infectious diseases.